Mylan Laboratories Limited has received a risk category 1 ranking from the WHO Expert Review Panel for its generic injectable, medroxyprogesterone acetate depot 150mg/ml.
News & Events
- WHO has just prequalified a combination mifepristone-misoprostol (combipack) for medical abortion
- WHO has just prequalified a combination mifepristone-misoprostol (combipack) for medical abortion
- A third quality assured, generic DMPA-IM product available for procurement
- From Concept Foundation: July 2019
- Concept Foundation announces A. Metin Gülmezoglu as its new Executive Director